麻醉剂市场（按药物类型、给药途径、作用持续时间、用途和最终用户划分）—2025-2030 年全球预测

麻醉剂市场预计到 2024 年将达到 88.1 亿美元，2025 年将达到 91.9 亿美元，到 2030 年将达到 114 亿美元，复合年增长率为 4.38%。

主要市场统计数据
基准年2024年	88.1亿美元
预计2025年	91.9亿美元
预测年份 2030	114亿美元
复合年增长率（%）	4.38%

麻醉剂的演变从根本上改变了医护人员在医疗过程中管理病患舒适度和安全的方式。从基本的植物抽取物到复杂的合成化合物，该领域不断创新，以降低风险、提高疗效并扩大临床应用范围。这段病人历程凸显了药理学、外科技术和以患者为中心的护理之间的关键交汇。

近期趋势，包括对动态和药物动力学的更深入理解，正在推动起效时间更快、安全性更高的药物的开发。同时，对微创外科手术的需求日益增长，使得能够加快恢復速度并减少术后併发症的麻醉剂变得尤为重要。这促使药物开发商、临床医生和监管机构之间的合作日益加强，为新一代麻醉解决方案铺平了道路。

随着医学界不断追求优化患者治疗效果，麻醉剂的角色仍然至关重要。全身麻醉药和局部麻醉剂的创新有望应对从复杂的外科手术到门诊病人疼痛管理等新的医疗保健挑战，因此，研究这些创新的动态对于整个医疗保健领域的相关人员至关重要。

新的变化正在重新定义麻醉剂领域，突破性技术不断实用化，监管的进步改善了患者的治疗效果

在技​​术突破和临床实践不断发展的推动下，麻醉剂领域正在经历显着变革。标靶给药系统和精准给药技术等尖端技术正在改善麻醉剂与神经系统的相互作用，从而最大限度地减少不利事件并提升患者舒适度。数位健康工具的整合进一步改善了手术全期监测，使得能够根据个体生理反应即时调整麻醉深度。

评估2025年美国关税调整对全球麻醉剂供应链、资源可用性和成本结构的深远影响

2025年美国新关税结构的推出对全球麻醉剂供应链产生了复杂的影响。关键前驱物和辅料的进口关税推高了原物料成本，促使製造商重新评估筹资策略，将可靠性置于价格之上。这些变化凸显了高度集中的供应网络的脆弱性，并促使企业转向多元化的采购管道。

详细的细分洞察揭示了麻醉剂市场对药物类型、途径、应用、持续时间和最终用户的关键观点

要了解麻醉剂市场，需要对各种麻醉药物在临床环境中的作用机制有深入的理解。全身麻醉剂已发展到能够快速诱导和恢復，而局部麻醉剂则提供靶向神经阻断。在局部麻醉剂中，酰胺类化合物起效时间较长，而酯类化合物起效较快，但起效时间较短。这些差异可以指导根据手术的复杂程度和患者风险因素选择合适的麻醉药物。

战略区域洞察，重点关注美洲、欧洲、中东、非洲和亚太地区的主要驱动力、挑战和成长机会

美洲地区继续受到高手术量、完善的法规结构以及日益重视门诊护理的驱动。对门诊手术中心的投资不断增加，推动了对速效和短效麻醉剂的需求，这些麻醉药可实现当天出院。此外，区域卫生当局正在推广基于价值的护理模式，以鼓励缩短住院时间并最大程度地减少不利事件。

透过合作伙伴管道和地理扩张塑造麻醉剂供应商未来的主要企业策略和竞争倡议

业界主要参与者正在采取各种策略性倡议，以增强其麻醉剂组合。领先的製药公司正在与专注于新型递送系统和前驱药物技术的生物技术公司进行有针对性的合作，丰富其产品线。这些合作旨在透过增强其安全性和拓宽其临床适应症，使其产品实现差异化。

为产业领导者提供可行的策略建议，以增强麻醉剂研发供应链的敏捷性和市场差异化

麻醉剂行业领导者应考虑跨部门合作，以加速创新并共用开发风险。与新兴企业和学术机构合作可以获得新型分子和先进的製剂技术，而共同开发契约可以简化商业化路径。同时，製造地多元化，纳入区域生产基地，可增强供应链对贸易中断的抵御能力。

稳健的调查方法结合了定性和定量方法，为麻醉剂领域提供准确且可行的见解

本研究采用综合混合方法框架，确保严谨性和可靠性。主要的质性研究结论透过与麻醉师、采购专业人员和监管专家进行结构化访谈收集，从而提供有关药物选择、临床偏好和新兴挑战的第一手观点。这些结论与来自同行评审期刊、临床试验註册中心和公开监管备案文件的数据进行整合，以检验技术发现。

结论性分析整合了关键见解和必要事项，以应对不断发展的麻醉剂领域的新兴趋势、风险和机会

本分析综合了影响麻醉剂领域的关键趋势、挑战和策略必要事项。从暴露供应链脆弱性的贸易政策变化，到精准给药技术的兴起，相关人员必须应对日益复杂的环境。关键的细分洞察强调了药物类型、给药途径、给药时长、应用和最终用户环境对于有效客製化产品系列的重要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 门诊手术对无鸦片类药物局部麻醉解决方案的需求激增
• 整合人工智慧，实现手术期间个人化麻醉管理和监测
• 越来越多采用静脉注射右Dexmedetomidine作为全身麻醉通讯协定的辅助手段
• 扩大超音波引导下週边神经阻断可提高疼痛管理的精确度
• 开发用于快速诱导和恢復的超短效麻醉剂
• 製药公司和设备製造商结成策略联盟，扩大麻醉剂传输系统
• 开发针对性麻醉剂配方以减少老年患者术后认知功能障碍
• 奈米粒子递送系统在长时间手术中持续释放局部麻醉剂的进展
• 儿科专用麻醉剂获得监管部门核准，以提高儿科手术的安全性和有效性
• 远距麻醉服务在手术全期护理中兴起，整合了远端监控和虚拟会诊

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

第八章麻醉剂市场（依药品类型）

• 全身麻醉
• 局部麻醉剂
  • 酰胺
  • 酯

第九章麻醉剂市场（依给药途径）

• 吸入
• 肌肉注射
• 静脉

第 10 章麻醉剂市场（依作用持续时间）

• 长效
• 短效

第11章麻醉剂市场（依应用）

• 牙科手术
  • 治疗
  • 预防措施
• 产科
• 疼痛管理
  • 急性疼痛
  • 慢性疼痛
• 外科手术
  • 心血管手术
  • 一般外科
  • 神经外科
  • 整形外科
  • 整形外科

第十二章麻醉剂市场（依最终用户）

• 门诊手术中心
• 医院和诊所

13.美洲麻醉剂市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

14.欧洲、中东和非洲麻醉剂市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

15.亚太麻醉剂市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十六章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Abbott Laboratories
  • Apotex Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • B. Braun SE
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Claris Lifesciences Limited
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Mylan NV
  • Novartis AG
  • Pacira Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Piramal Enterprises LTD
  • Septodont Healthcare India Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.
  • Weefsel Pharma

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

The Anesthetic Drugs Market was valued at USD 8.81 billion in 2024 and is projected to grow to USD 9.19 billion in 2025, with a CAGR of 4.38%, reaching USD 11.40 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 8.81 billion
Estimated Year [2025]	USD 9.19 billion
Forecast Year [2030]	USD 11.40 billion
CAGR (%)	4.38%

The evolution of anesthetic drugs has fundamentally transformed the way healthcare professionals manage patient comfort and safety during medical procedures. From rudimentary plant extracts to sophisticated synthetic compounds, the field has undergone relentless innovation to reduce risk, improve efficacy, and broaden the scope of clinical applications. This journey underscores the vital intersection between pharmacology, surgical technique, and patient-centered care.

In recent years, a deeper understanding of pharmacodynamics and pharmacokinetics has driven the development of agents with faster onset times and enhanced safety profiles. At the same time, rising demand for minimally invasive surgical techniques has placed a premium on anesthetic drugs that enable rapid recovery and reduce postoperative complications. Consequently, collaboration across drug developers, clinicians, and regulatory bodies has accelerated, paving the way for a new generation of anesthetic solutions.

As the medical community continues to pursue optimized patient outcomes, the role of anesthetic drugs remains central. Innovations in both general and local anesthetic formulations are poised to address emerging healthcare challenges, from complex surgical interventions to outpatient pain management, making the study of their dynamics indispensable for stakeholders across the continuum of care.

Emerging Transformations Redefining the Anesthetic Landscape Through Breakthrough Technologies Practices and Regulatory Advancements Enhancing Patient Outcomes

The anesthetic drug sector is experiencing remarkable shifts propelled by technological breakthroughs and evolving clinical practices. Cutting-edge advances such as targeted delivery systems and precision dosing technologies are refining how anesthetics interact with the nervous system, thereby minimizing adverse events and optimizing patient comfort. Integrating digital health tools has further improved perioperative monitoring, allowing real-time adjustments to anesthesia depth based on individual physiological responses.

Regulatory landscapes are also playing a transformative role. Newly implemented guidelines emphasize rigorous safety assessments, streamlined approval pathways, and post-market surveillance tailored to address emerging risks such as rare allergic reactions or potential neurotoxicity. This regulatory momentum, coupled with heightened patient awareness around procedural safety, is encouraging pharmaceutical companies to invest heavily in differentiated products that demonstrate clear clinical advantages.

Transitioning from traditional formulations to next-generation molecules requires robust collaboration among academic research centers, biotech innovators, and established pharmaceutical firms. The convergence of artificial intelligence for drug discovery, nanotechnology for targeted delivery, and enhanced formulation science is setting the stage for anesthetic agents that adapt dynamically to procedural demands, ultimately redefining standards of care.

Assessing the Far Reaching Effects of United States Tariff Adjustments Set for 2025 on Global Anesthetic Drug Supply Chains Resource Availability and Cost Structures

The introduction of new tariff structures by the United States in 2025 has led to complex reverberations throughout the global anesthetic drug supply chain. Import duties on key precursors and excipients have heightened raw material costs, prompting manufacturers to reevaluate sourcing strategies and prioritize reliability alongside price. These changes have underscored the vulnerability of highly centralized supply networks, catalyzing a shift towards diversified procurement channels.

Consequently, several major producers have begun to establish regional production hubs to mitigate cost volatility and buffer against unexpected trade policy shifts. While this move toward nearshoring offers greater supply security, it also demands significant capital investment and compliance with local regulatory frameworks. As a result, stakeholders are collaborating with logistics specialists and regulatory experts to ensure seamless cross-border workflows that maintain product quality and consistency.

Moreover, healthcare providers are adapting by optimizing inventory management systems and forging strategic partnerships with suppliers to secure prioritized access. In parallel, ongoing dialogue between industry associations and policymakers is seeking to balance national economic objectives with uninterrupted patient care. Thus, the accelerated tariff environment has become a catalyst for both operational resilience and innovative supply chain redesign.

In Depth Segmentation Insights Unveiling Critical Perspectives on Drug Types Routes Applications Durations and End Users in the Anesthetic Market

Understanding the anesthetic drugs market requires a nuanced appreciation of how diverse drug types perform across clinical contexts. General anesthetics have evolved to provide rapid induction and recovery, while local anesthetics offer targeted nerve blockade. Within the local segment, amide-based compounds deliver longer durations of action, whereas ester-based agents offer rapid onset but shorter persistence. These distinctions inform drug selection depending on procedural complexity and patient risk factors.

Administration route further refines therapeutic approaches. Inhalation anesthetics allow precise titration during extensive surgical interventions, whereas intramuscular formulations serve as practical options in settings lacking intravenous access. Intravenous delivery remains the gold standard for rapid sedation and intraoperative control. Clinicians weigh onset speed against procedural requirements to match route selection with clinical objectives.

Duration of action also influences drug utilization. Long-acting agents support extended surgical procedures and postoperative analgesia, while short-acting compounds facilitate brief interventions and enable swift patient turnover. This temporal dimension of anesthetic planning is critical for balancing efficacy, safety, and resource allocation.

Applications span a wide spectrum of medical specialties. In dental care, injectable anesthetics enable both operative and preventive treatments, ensuring patient comfort during routine procedures. Obstetric anesthesia requires careful dosing strategies to balance maternal analgesia with fetal safety. Pain management leverages acute formulations to address postoperative discomfort and chronic options to alleviate long-term conditions. Surgical procedures demand specialized agents for cardiac surgery, general surgery, neurosurgery, orthopedic operations, and plastic surgery, each with unique anesthetic requirements.

Finally, the end users of anesthetic drugs operate in distinct environments. Ambulatory surgical centers emphasize rapid patient throughput and minimal recovery times, while hospitals and clinics require versatile anesthetic portfolios to cover diverse procedural needs. Together, these segmentation lenses reveal critical trade-offs and optimization pathways in formulating, administering, and delivering anesthetics effectively.

Strategic Regional Insights Highlighting Key Drivers Challenges and Growth Opportunities Across Americas EMEA and Asia Pacific Territories

The Americas region continues to be driven by extensive surgical volumes, well-established regulatory frameworks, and a growing focus on ambulatory care. Heightened investment in outpatient surgical centers is fostering demand for rapid-onset, short-acting anesthetics that support same-day discharge. In addition, regional health authorities are promoting value-based care models that incentivize reduced hospital stays and minimized adverse events.

Within Europe, the Middle East and Africa, regulatory harmonization initiatives such as centralized approval processes have facilitated the entry of innovative anesthetic compounds across multiple jurisdictions. Yet market maturity varies widely, with advanced economies prioritizing next-generation agents and emerging markets focusing on cost-effective generics. In parallel, infrastructure development projects in certain Middle Eastern and African nations are expanding surgical capacity, creating fresh opportunities for anesthetic providers.

The Asia-Pacific region is characterized by rapid modernization of healthcare infrastructure and growing surgical caseloads. Emerging economies in Southeast Asia and South Asia are witnessing increased access to elective procedures, fueling demand for both general and local anesthetics. Moreover, investments in domestic manufacturing capabilities are reducing reliance on imports and positioning local players to compete in regional export markets. As a result, the Asia-Pacific landscape presents a dynamic interplay of innovation, capacity building, and escalating patient demand.

Key Corporate Strategies and Competitive Moves Shaping the Future of Anesthetic Drug Suppliers Through Partnerships Pipelines and Geographic Expansion

Major industry players are pursuing a variety of strategic moves to strengthen their anesthetic drug portfolios. Leading pharmaceutical companies are deepening their pipelines through targeted partnerships with biotechnology firms specializing in novel delivery systems and prodrug technologies. Such collaborations aim to differentiate products by enhancing safety profiles and expanding clinical indications.

In parallel, several organizations are investing in regional expansion, establishing manufacturing and distribution centers closer to key customer bases. This geographic diversification not only reduces lead times but also supports compliance with local regulatory requirements. These efforts are often complemented by acquisitions of smaller niche players, enabling larger firms to incorporate specialized expertise and fill portfolio gaps rapidly.

Research and development remains a critical focus area, with emphasis on integrating digital health platforms for anesthesia monitoring and management. By embedding smart monitoring technologies and leveraging data analytics, companies are seeking to provide comprehensive perioperative solutions that go beyond conventional drug delivery. These initiatives are aligned with broader trends toward personalized medicine and value-based care.

Actionable Strategic Recommendations for Industry Leaders to Strengthen Research Development Supply Chain Agility and Market Differentiation in Anesthetics

Leaders in the anesthetic drug industry should consider forging cross-sector alliances to accelerate innovation and share development risks. Engaging with startups and academic institutions can provide access to novel molecules and advanced formulation techniques, while co-development agreements can streamline commercialization pathways. Simultaneously, diversifying manufacturing footprints by incorporating regional production hubs will enhance supply chain resilience against trade disruptions.

Adopting digital platforms for anesthesia management presents another opportunity. Integrating real-time monitoring tools and predictive analytics into clinical workflows can optimize agent selection, dosage calibration, and patient recovery protocols. This technological convergence will strengthen value propositions for providers and improve overall patient safety.

Furthermore, tailoring regional strategies to local regulatory and clinical environments is essential. In mature markets, emphasizing differentiated, high-value products that support out-patient procedures can yield competitive advantage, while in emerging markets, cost-effective portfolios and flexible distribution partnerships will drive adoption. By adopting a dual approach that balances innovation with affordability, companies can capture diverse market segments effectively.

Robust Research Methodology Combining Qualitative and Quantitative Approaches to Deliver Accurate and Actionable Insights into the Anesthetic Drug Landscape

This research draws on a comprehensive mixed-methodology framework to ensure rigor and reliability. Primary qualitative insights were gathered through structured interviews with anesthesiologists, procurement specialists, and regulatory experts, providing firsthand perspectives on drug selection, clinical preferences, and emerging challenges. These insights were triangulated with data from peer-reviewed journals, clinical trial registries, and publicly available regulatory filings to validate technical findings.

Quantitative assessments incorporated detailed analysis of trade data, ingredient sourcing patterns, and facility output to map supply chain dynamics. Advanced statistical techniques were employed to detect trends and identify key drivers of change. In addition, a panel of independent industry veterans reviewed all findings to ensure objectivity and contextual accuracy.

Throughout the study, robust data quality protocols were applied, including source verification, consistency checks, and iterative feedback loops with subject matter experts. This multilayered approach delivers a cohesive picture of the anesthetic drug landscape, equipping decision-makers with actionable insights grounded in empirical evidence and expert validation.

Conclusive Analysis Synthesizing Key Findings and Imperatives to Navigate Emerging Trends Risks and Opportunities in the Evolving Anesthetic Drug Sector

This analysis synthesizes the critical trends, challenges, and strategic imperatives shaping the anesthetic drugs arena. From materializing supply chain vulnerabilities under shifting trade policies to the advent of precision administration technologies, stakeholders must navigate an increasingly complex environment. Key segmentation insights underscore the importance of drug type, administration route, duration, application, and end-user context in tailoring product portfolios effectively.

Regional dynamics further emphasize the need for adaptive strategies, balancing innovation and cost efficiency across diverse healthcare systems. Corporate maneuvers, including alliances, acquisitions, and digital integrations, highlight competitive priorities in securing long-term growth. By leveraging a robust mixed-methodology framework, this report delivers validated insights to guide strategic decision-making.

Moving forward, collaboration across the value chain-from raw material suppliers to end-user institutions-will be instrumental in driving enhanced patient outcomes while safeguarding operational resilience. This comprehensive conclusion invites stakeholders to refine their approach in line with emerging technological, regulatory, and market forces, laying a foundation for sustained leadership in the evolving anesthetic drug sector.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Surge in demand for opioid-free regional anesthesia solutions in outpatient procedures
• 5.2. Integration of artificial intelligence for personalized anesthetic dosing and monitoring during surgery
• 5.3. Growing adoption of intravenous dexmedetomidine as adjunct to general anesthesia protocols
• 5.4. Expansion of ultrasound-guided peripheral nerve blocks improving precision in pain management
• 5.5. Increasing development of ultra-short acting anesthetics for rapid induction and recovery times
• 5.6. Strategic alliances between pharmaceutical companies and device makers to expand anesthetic delivery systems
• 5.7. Development of targeted anesthetic formulations to reduce postoperative cognitive dysfunction in elderly patients
• 5.8. Advances in nanoparticle-based delivery systems enabling sustained release of regional anesthetics during prolonged surgeries
• 5.9. Regulatory approval of pediatric-specific anesthetic agents enhancing safety and efficacy in child surgeries
• 5.10. Rise of tele-anesthesia services integrating remote monitoring and virtual consultations in perioperative care

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Anesthetic Drugs Market, by Drug Type

• 8.1. Introduction
• 8.2. General Anesthetics
• 8.3. Local Anesthetics
  • 8.3.1. Amides
  • 8.3.2. Esters

9. Anesthetic Drugs Market, by Administration Route

• 9.1. Introduction
• 9.2. Inhalation
• 9.3. Intramuscular
• 9.4. Intravenous

10. Anesthetic Drugs Market, by Duration of Action

• 10.1. Introduction
• 10.2. Long-Acting
• 10.3. Short-Acting

11. Anesthetic Drugs Market, by Application

• 11.1. Introduction
• 11.2. Dental Procedures
  • 11.2.1. Operative
  • 11.2.2. Preventive
• 11.3. Obstetrics
• 11.4. Pain Management
  • 11.4.1. Acute Pain
  • 11.4.2. Chronic Pain
• 11.5. Surgical Procedures
  • 11.5.1. Cardiac Surgery
  • 11.5.2. General Surgery
  • 11.5.3. Neuro Surgery
  • 11.5.4. Orthopedic Surgery
  • 11.5.5. Plastic Surgery

12. Anesthetic Drugs Market, by End User

• 12.1. Introduction
• 12.2. Ambulatory Surgical Centers
• 12.3. Hospitals & Clinics

13. Americas Anesthetic Drugs Market

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. Argentina

14. Europe, Middle East & Africa Anesthetic Drugs Market

• 14.1. Introduction
• 14.2. United Kingdom
• 14.3. Germany
• 14.4. France
• 14.5. Russia
• 14.6. Italy
• 14.7. Spain
• 14.8. United Arab Emirates
• 14.9. Saudi Arabia
• 14.10. South Africa
• 14.11. Denmark
• 14.12. Netherlands
• 14.13. Qatar
• 14.14. Finland
• 14.15. Sweden
• 14.16. Nigeria
• 14.17. Egypt
• 14.18. Turkey
• 14.19. Israel
• 14.20. Norway
• 14.21. Poland
• 14.22. Switzerland

15. Asia-Pacific Anesthetic Drugs Market

• 15.1. Introduction
• 15.2. China
• 15.3. India
• 15.4. Japan
• 15.5. Australia
• 15.6. South Korea
• 15.7. Indonesia
• 15.8. Thailand
• 15.9. Philippines
• 15.10. Malaysia
• 15.11. Singapore
• 15.12. Vietnam
• 15.13. Taiwan

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Abbott Laboratories
  • 16.3.2. Apotex Inc.
  • 16.3.3. Aspen Pharmacare Holdings Limited
  • 16.3.4. AstraZeneca PLC
  • 16.3.5. B. Braun SE
  • 16.3.6. Baxter International Inc.
  • 16.3.7. Boehringer Ingelheim International GmbH
  • 16.3.8. Claris Lifesciences Limited
  • 16.3.9. Eisai Co. Ltd.
  • 16.3.10. F. Hoffmann-La Roche Ltd.
  • 16.3.11. Fresenius SE & Co. KGaA
  • 16.3.12. Hikma Pharmaceuticals PLC
  • 16.3.13. Mylan N.V.
  • 16.3.14. Novartis AG
  • 16.3.15. Pacira Pharmaceuticals, Inc.
  • 16.3.16. Pfizer Inc.
  • 16.3.17. Piramal Enterprises LTD
  • 16.3.18. Septodont Healthcare India Pvt. Ltd.
  • 16.3.19. Sun Pharmaceutical Industries Ltd.
  • 16.3.20. Teva Pharmaceutical Industries Limited
  • 16.3.21. Viatris Inc.
  • 16.3.22. Weefsel Pharma

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

• FIGURE 1. ANESTHETIC DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 16. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 18. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 23. ANESTHETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 24. ANESTHETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 25. ANESTHETIC DRUGS MARKET: RESEARCHAI
• FIGURE 26. ANESTHETIC DRUGS MARKET: RESEARCHSTATISTICS
• FIGURE 27. ANESTHETIC DRUGS MARKET: RESEARCHCONTACTS
• FIGURE 28. ANESTHETIC DRUGS MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. ANESTHETIC DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMIDES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ESTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ESTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LONG-ACTING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OPERATIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OPERATIVE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PREVENTIVE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OBSTETRICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OBSTETRICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 55. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 57. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 59. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 61. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY NEURO SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY NEURO SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 63. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 65. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 67. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 69. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 71. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 73. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 75. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 76. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 77. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 78. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 79. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 80. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 81. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 82. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 83. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 84. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 85. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 86. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 87. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 88. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 89. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 90. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 91. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 92. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 93. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 95. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 96. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 97. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 98. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 99. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 100. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 101. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 102. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 103. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 104. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 105. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 106. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 107. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 108. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 109. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 110. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 111. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 112. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 113. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 114. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 115. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 116. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 117. CANADA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 118. CANADA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 119. CANADA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 120. CANADA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 121. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 122. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 123. CANADA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 124. CANADA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 125. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 126. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 127. CANADA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 128. CANADA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 129. CANADA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 130. CANADA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 131. CANADA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 132. CANADA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 133. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 134. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 135. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 136. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 137. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 138. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 139. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 140. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 141. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 142. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 143. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 144. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 145. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 146. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 147. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 148. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 149. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 150. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 151. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 152. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 153. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 154. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 155. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 156. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 157. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 158. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 159. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 160. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 161. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 162. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 163. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 164. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 165. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 166. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 167. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 168. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 169. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 170. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 171. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 172. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 173. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 174. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 175. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 176. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 177. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 178. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 179. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 180. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 181. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 182. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 183. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 184. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 185. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 186. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 207. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 208. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 209. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 210. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 211. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 212. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 213. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 214. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 215. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 216. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 217. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 218. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 219. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 220. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 221. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 222. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 223. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 224. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 225. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 226. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 227. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 228. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 229. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 230. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 231. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 232. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 233. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 234. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 235. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 236. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 237. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 238. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 239. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 240. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 241. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 242. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 243. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 244. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 245. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 246. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 247. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 248. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 249. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 250. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 251. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 252. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 253. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 254. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 255. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 256. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 257. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 258. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 259. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 261. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 262. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 263. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 264. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 265. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 266. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 267. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 268. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 269. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 270. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 271. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 272. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 273. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 274. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 275. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 276. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 277. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 278. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 279. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 280. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 281. ITALY ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 282. ITALY ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 283. ITALY ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 284. ITALY ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 285. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 286. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 287. ITALY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 288. ITALY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 289. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 290. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 291. ITALY ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 292. ITALY ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 293. ITALY ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 294. ITALY ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 295. ITALY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 296. ITALY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 297. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 298. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 299. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 300. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 301. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 302. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 303. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 304. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 305. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 306. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 307. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 308. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 309. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 310. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 311. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 312. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 313. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 314. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 324. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 325. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 326. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 327. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 328. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
• TABLE 329. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
• TABLE 330. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
• TABLE 331. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 332. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 333. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
• TABLE 334. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
• TABLE 335. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
• TABLE 336. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
• TABLE 337. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
• TABLE 338. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
• TABLE 339. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2024 (USD MILLION)
• TABLE 340. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025-2030 (USD MILLION)
• TABLE 341. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 342. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 343. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, B